Correlation Between Fate Therapeutics and Allogene Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Allogene Therapeutics, you can compare the effects of market volatilities on Fate Therapeutics and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Allogene Therapeutics.

Diversification Opportunities for Fate Therapeutics and Allogene Therapeutics

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Fate and Allogene is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Allogene Therapeutics go up and down completely randomly.

Pair Corralation between Fate Therapeutics and Allogene Therapeutics

Given the investment horizon of 90 days Fate Therapeutics is expected to generate 1.25 times more return on investment than Allogene Therapeutics. However, Fate Therapeutics is 1.25 times more volatile than Allogene Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  287.00  in Fate Therapeutics on August 29, 2024 and sell it today you would lose (19.00) from holding Fate Therapeutics or give up 6.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fate Therapeutics  vs.  Allogene Therapeutics

 Performance 
       Timeline  
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Allogene Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Allogene Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Allogene Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Fate Therapeutics and Allogene Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fate Therapeutics and Allogene Therapeutics

The main advantage of trading using opposite Fate Therapeutics and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.
The idea behind Fate Therapeutics and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets